Chronic Myeloid Leukemia Presenting With T-Lymphoid Blast Crisis in a Young Female With Marked Hyperleukocytosis: A Case Report [0.03%]
一名年轻女性慢性髓系白血病伴T淋系急变期的病例报告
E Somasundaram,R P Hasserjian,B J Aubrey et al.
E Somasundaram et al.
Background: Chronic myeloid leukemia (CML) presenting in blast crisis (BC) is uncommon in the era of tyrosine kinase inhibitor (TKI) treatment, and T-lymphoblastic BC is exceptionally rare. We report a case of T-lymphoid ...
Patient Journey, Treatment Patterns, and Disease Burden of Patients With Idiopathic Hypereosinophilic Syndrome [0.03%]
特发性高嗜酸细胞综合征患者的就医经历、治疗模式和疾病负担
Juliana Schwaab,Paul Dolin,Bo Ding et al.
Juliana Schwaab et al.
Introduction: Idiopathic hypereosinophilic syndrome (I-HES) is a rare disorder characterized by persistent eosinophilia without an identifiable underlying cause, leading to organ damage and dysfunction. The objectives of ...
Choroidal Leakage during Daratumumab Therapy: A Desensitization-Based Strategy for Treatment Continuation in Relapsed/Refractory Multiple Myeloma [0.03%]
达雷妥尤单抗治疗过程中脉络膜渗漏:持续治疗复发/难治性多发性骨髓瘤的脱敏策略
Metban Mastanzade,Zafer Cebeci,Kıvanç Koruk et al.
Metban Mastanzade et al.
Background: Daratumumab is widely used in relapsed/refractory multiple myeloma, but ocular adverse events are rare and not well-characterized. Case presen...
Anemia and Patient-Reported Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: A Real-World Observational Study [0.03%]
阵发性夜间血红蛋白尿患者贫血与患者报告结果的关联:一项真实世界观察研究
Esther Natalie Oliva,Antonio M Risitano,Eros Di Bona et al.
Esther Natalie Oliva et al.
Introduction: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematologic disorder characterized by complement-mediated hemolysis, thrombosis, bone marrow failure, and anemia. Although current treatments improve outco...
Correction to "Transcranial Doppler Ultrasound Velocity Measurements in Children With Sickle Cell Disease in Kenya" [0.03%]
对“肯尼亚镰状细胞病儿童经颅多普勒超声测速”的勘误通知
[This corrects the article DOI: 10.1002/jha2.70312.]. © 2026 The Author(s). eJHaem published by British Society for Haematology and John Wiley & Sons Lt...
Published Erratum
EJHaem. 2026 Aug 7;7(4):e70380. DOI:10.1002/jha2.70380 2026
Subclinical Cardiac Changes Following CPX-351 Induction in Adults with Favorable/Intermediate-Risk AML [0.03%]
CPX-351诱导后成人有利/中危急性髓系白血病患者的心脏亚临床改变
Chezi Ganzel,Avraham Frisch,Ofir Wolach et al.
Chezi Ganzel et al.
CPX-351 is associated with reduced non-hematologic toxicity, but its cardiac safety is not well defined. We prospectively assessed ejection fraction (EF) and global longitudinal strain (GLS) in younger adults with AML treated with a single ...
Untreated Thalassemia Associated With Facial and Dental Changes in Adulthood [0.03%]
未治疗的地中海贫血与成人期面部和牙齿变化有关
Miranda Lin,Ivana Ho,Richard C Godby
Miranda Lin
DNMT3A Co-Mutation and Real-World Clinical Outcomes With Gilteritinib in FLT3-Mutated Acute Myeloid Leukaemia Across Molecular Subgroups [0.03%]
FLT3突变阳性急性髓系白血病患者中吉列替尼的真实世界疗效与DNA甲基转移酶3A共突变及分子亚型的关系研究
Francesca Duca,Beatrice Manghisi,Andrea Palasciano et al.
Francesca Duca et al.
Introduction: Molecular co-mutations modulate outcomes in FLT3-mutated AML treated with gilteritinib; real-world data stratified by DNMT3A co-mutation status are lacking. ...
Infection Incidence and Survival in Patients With Multiple Myeloma and Chronic Lymphocytic Leukaemia: A Growing Concern in the Era of Modern Therapies [0.03%]
现代治疗时代多发性骨髓瘤和慢性淋巴细胞白血病患者的感染发病率和生存率:日益增长的关注点
Ingrid Glimelius,Love Tätting,Jonatan Freilich et al.
Ingrid Glimelius et al.
Introduction: Patients with multiple myeloma (MM) and chronic lymphocytic leukaemia (CLL) are burdened by immunodeficiency due to treatment and underlying disease. Infection-related mortality remains a significant concern...
Sacha Mandel,Jean-François Lesesve
Sacha Mandel